Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

ResMed Inc (RMD)

  • Business News
  • Dec. 24, 2025, 23:26 UTC
  • 20
  • 1 comments

ResMed Inc. Daily Stock Update

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Dec. 24, 2025, 22:56 UTC
  • 18
  • 1 comments

How to Connect A Meta Quest to a TV

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Dec. 24, 2025, 22:46 UTC
  • 15
  • 1 comments

Apple Watch Ultra 3 Review For 2026

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Dec. 24, 2025, 22:42 UTC
  • 17
  • 1 comments

Best Headphones for Music: Top Picks for Audiophiles in 2026

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Dec. 24, 2025, 22:41 UTC
  • 16
  • 1 comments

How Much Are AirPod Pros?

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • Dec. 24, 2025, 22:22 UTC
  • 12
  • 1 comments

Latest About OnePlus 13: Specs, Latest Updates, and Release Info

Market reaction Comment Full text

TransMedics Group Inc. (TMDX)

  • Business News
  • Dec. 24, 2025, 21:05 UTC
  • 14
  • 1 comments

TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Market reaction Comment Full text

XTL Biopharmaceuticals Ltd. (XTLB)

  • Business News
  • Dec. 24, 2025, 21:00 UTC
  • 10
  • 1 comments

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Market reaction Comment Full text

SOBR Safe, Inc. (SOBR)

  • Business News
  • Dec. 24, 2025, 20:31 UTC
  • 12
  • 1 comments

SOBRsafe Announces $2 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Market reaction Comment Full text

Perrigo Company plc (PRGO)

  • Business News
  • Dec. 24, 2025, 19:53 UTC
  • 13
  • 1 comments

Perrigo Company plc (PRGO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Market reaction Comment Full text
  • Previous
  • 227
  • 228
  • 229
  • 230
  • 231
  • Next

Search

News categories

  • Technical Exchange News(10887)
  • Event(2275)
  • SEC News(189743)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124649)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin